Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cureus ; 16(1): e53153, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38420074

RESUMEN

Serum levels of butyrylcholinesterase (BChE) are commonly used to assess liver function. Its levels have been reported to be significantly lower in patients undergoing dialysis. To the best of our knowledge, this is the first report of hereditary heterozygous BChE deficiency in a patient undergoing dialysis. Medical staff involved in the care of patients with BChE deficiency should be aware of anesthetic usage, because prolonged neuromuscular paralysis following the administration of succinylcholine or mivacurium may occur. However, in the heterozygotes, BChE activity is not completely absent. Therefore, differentiating patients undergoing dialysis is challenging. A 52-year-old man underwent living-related kidney transplantation for focal segmental glomerulosclerosis at 22 years of age. As the renal function gradually worsened, the patient began to receive combined hemodialysis and peritoneal dialysis therapy. No problems with anesthesia were observed in past surgeries. The patient's BChE levels fluctuated between 76 and 170 U/L (reference range: 198-495 U/L); however, they had never been previously investigated. We suspected hereditary heterozygous BChE deficiency because the patient's sister was also diagnosed with it. DNA sequencing revealed a heterozygous missense mutation (Gly365Arg) and a K-variant (Ala539Thr). Patients on dialysis with low serum BChE levels often present with low albumin levels which may be overlooked as malnutrition. Thus, BChE deficiency should be suspected in patients on dialysis with unexplained low serum BChE levels. In the case of heterozygous BChE deficiency, the reference value is low, and continuous monitoring is crucial.

2.
J Hepatol ; 66(2): 363-373, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27742377

RESUMEN

BACKGROUND & AIMS: Patients with hepatocellular carcinoma (HCC) have a high-risk of multi-centric (MC) tumor occurrence due to a strong carcinogenic background in the liver. In addition, they have a high risk of intrahepatic metastasis (IM). Liver tumors withIM or MC are profoundly different in their development and clinical outcome. However, clinically or pathologically discriminating between IM and MC can be challenging. This study investigated whether IM or MC could be diagnosed at the molecular level. METHODS: We performed whole genome and RNA sequencing analyses of 49 tumors including two extra-hepatic metastases, and one nodule-in-nodule tumor from 23 HCC patients. RESULTS: Sequencing-based molecular diagnosis using somatic single nucleotide variation information showed higher sensitivity compared to previous techniques due to the inclusion of a larger number of mutation events. This proved useful in cases, which showed inconsistent clinical diagnoses. In addition, whole genome sequencing offered advantages in profiling of other genetic alterations, such as structural variations, copy number alterations, and variant allele frequencies, and helped to confirm the IM/MCdiagnosis. Divergent alterations between IM tumors with sorafenib treatment, long time-intervals, or tumor-in-tumor nodules indicated high intra-tumor heterogeneity, evolution, and clonal switching of liver cancers. CONCLUSIONS: It is important to analyze the differences between IM tumors, in addition to IM/MC diagnosis, before selecting a therapeutic strategy for multiple tumors in the liver. LAY SUMMARY: Whole genome sequencing of multiple liver tumors enabled the accuratediagnosis ofmulti-centric occurrence and intrahepatic metastasis using somatic single nucleotide variation information. In addition, genetic discrepancies between tumors help us to understand the physical changes during recurrence and cancer spread.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Metástasis de la Neoplasia , Neoplasias Primarias Múltiples , Adulto , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patología , Carcinoma Hepatocelular/terapia , Variaciones en el Número de Copia de ADN , Femenino , Estudio de Asociación del Genoma Completo , Humanos , Japón , Hígado/patología , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/terapia , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia/genética , Metástasis de la Neoplasia/patología , Metástasis de la Neoplasia/terapia , Neoplasias Primarias Múltiples/genética , Neoplasias Primarias Múltiples/patología , Neoplasias Primarias Múltiples/terapia , Selección de Paciente , Secuenciación Completa del Genoma/métodos
4.
ACS Appl Mater Interfaces ; 7(44): 24492-500, 2015 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-26465161

RESUMEN

Highly efficient electrohydrodynamic (EHD) pumping was obtained by a combination of a dielectric liquid having a molecular isomer and electrodes with a smooth surface. Four kinds of surface states of Cu electrodes were processed by conventional mechanical polishing, fine diamond paste polishing, chemical etching and Au vapor deposition. A series of hydrofluoroether liquids (HFEs) were used as dielectric liquids: C3F7OCH3 (HFE-7000), C4F9OCH3 (HFE-7100), C4F9OC2H5 (HFE-7200), C6F13OCH3 (HFE-7300), and C5H5F6OC3HF6 (HFE-7600). The coexistence of normal (n-) and isomer (i-) HFEs and their molar fractions were examined by NMR spectroscopy. Among the dielectric liquids, the hybrid n- and i-HFE-7600 showed highly efficient EHD pumping, where the electric current, I, was sufficiently suppressed by the smooth surface of the electrodes. The maximum hydrostatic pressure Δpmax was ∼7500 Pa with 12 kV and I = 19 µA. The smooth surface of the electrodes contributes not only to the formation of a stable electric double layer (EDL) but also to the prevention of charge injection from the electrodes. Polarization pumping derived from the stable EDL enables highly efficient energy transfer without discharging, or damage to the sample and electrodes. The dipole moments of the HFEs were estimated by density functional theory calculations. The hydrostatic pressure was found to be proportional to the difference in the calculated dipole moment between n- and i-HFEs. Numerical simulations were carried out to examine the experimentally obtained electrode gap dependence of the hydrostatic pressure.

5.
Biopolymers ; 91(8): 665-75, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19353641

RESUMEN

2SS[6-127,64-80] variant of lysozyme which has two disulfide bridges, Cys6-Cys127 and Cys64-Cys80, and lacks the other two disulfide bridges, Cys30-Cys115 and Cys76-Cys94, was quite unstructured in water, but a part of the polypeptide chain was gradually frozen into a native-like conformation with increasing glycerol concentration. It was monitored from the protection factors of amide hydrogens against H/D exchange. In solution containing various concentrations of glycerol, H/D exchange reactions were carried out at pH* 3.0 and 4 degrees C. Then, (1)H-(15)N-HSQC spectra of partially deuterated protein were measured in a quenching buffer for H/D exchange (95% DMSO/5% D(2)O mixture at pH* 5.5 adjusted with dichloroacetate). In a solution of 10% glycerol, the protection factors were nearly equal to 10 at most of residues. With increasing glycerol concentration, some selected regions were further protected, and their protection factors reached about a 1000 in 30% glycerol solution. The highly protected residues were included in A-, B-, and C-helices and beta3-strand, and especially centered on Ile 55 and Leu 56. In 2SS[6-127,64-80], long-range interactions were recovered due to the preferential hydration by glycerol in the hydrophobic box of the alpha-domain. Glycerol-induced recovering of the native-like structure is discussed from the viewpoint of molten globules growing with the protein folding. (c) 2009 Wiley Periodicals, Inc. Biopolymers 91: 665-675, 2009.This article was originally published online as an accepted preprint. The "Published Online" date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com.


Asunto(s)
Muramidasa/química , Animales , Pollos , Óxido de Deuterio , Disulfuros/química , Variación Genética , Glicerol/farmacología , Técnicas In Vitro , Modelos Moleculares , Muramidasa/genética , Resonancia Magnética Nuclear Biomolecular , Conformación Proteica/efectos de los fármacos , Pliegue de Proteína/efectos de los fármacos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética
6.
Semin Thromb Hemost ; 28(6): 495-500, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12536338

RESUMEN

The purpose of this study was to establish a new coagulation index to distinguish severe preeclampsia from normal pregnancy using optimal coagulation parameters. The difference between platelet counts in early gestation and before delivery (DeltaPlt = [platelet counts before delivery] - [platelet counts in early gestation]) was calculated as an index of changes in platelet counts. Antithrombin (AT) activity, thrombin-antithrombin (TAT) complex, fibrin degradation products (FDP) D-dimer, and DeltaPlt were investigated in 72 cases of normal pregnant women in the third trimester of pregnancy and 56 cases of severe preeclampsia. The new coagulation index was calculated using multivariate logistic regression analysis. As a result, in a case using four parameters, the following formula was obtained: Y = (-0.019 x AT activity) + (0.067 x TAT) + (0.067 x D-dimer) + (-0.064 x DeltaPlt) + 0.706. According to this formula, coagulation indices in normal pregnant women and in patients with severe preeclampsia were -0.77 +/- 0.51 and 1.41 +/- 1.56, respectively (p < 0.0001). Among patients with severe preeclampsia, coagulation and fibrinolysis disorders before delivery were typical in patients terminated by cesarean section (coagulation index = 1.62 +/- 1.66) compared with those with successful vaginal delivery (coagulation index = 0.52 +/- 0.34) (p < 0.05). These facts suggest that an excessive hypercoagulable state is associated with the termination of pregnancy resulting from the aggravation of preeclampsia. From the viewpoint of coagulation and fibrinolysis disorders, the predictive value in order to decide the optimal time for the termination of pregnancy could be recommended when the coagulation index exceeded 1.20.


Asunto(s)
Coagulación Sanguínea , Preeclampsia/sangre , Antitrombinas/metabolismo , Pruebas de Coagulación Sanguínea/métodos , Estudios de Casos y Controles , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Fibrinólisis , Humanos , Trabajo de Parto Inducido , Análisis Multivariante , Recuento de Plaquetas , Preeclampsia/diagnóstico , Preeclampsia/terapia , Embarazo , Trombina/metabolismo , Factores de Tiempo
7.
Semin Thromb Hemost ; 28(6): 511-4, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12536341

RESUMEN

Severe preeclampsia is a pathophysiological disorder specific to pregnancy and characterized by vasoconstriction and hypercoagulability. Eclampsia (convulsion associated with preeclampsia) and hemolysis, elevated liver enzymes, and low platelet count associated with preeclampsia (HELLP syndrome) are serious complications in patients with severe preeclampsia. They are thought to be characterized by generalized vasoconstriction and reduction in blood flow to various organs that may be explained by increased sensitivity of the vascular smooth muscles and increased vasopressors. Liver involvement in eclampsia and preeclampsia is referred to as HELLP syndrome, and epigastric and right upper quadrant pain is often a symptom of severe preeclampsia and may be indicative of imminent convulsions. In addition, marked dilatation of the stomach and the colon is often demonstrated in these patients. These phenomena result from the hyperactivity of the sympathetic nervous system but are not caused by the hyperactivity of the parasympathetic nervous system. The authors experienced two cases of eclamptic seizures after the administration of an anticholinergic (scopolamine butylbromide) in patients with severe preeclampsia complicated by HELLP syndrome. Anticholinergics, blocking agents of the parasympathetic nervous system, can enhance the hyperactivity of the sympathetic nervous system; therefore, vasospasms of the vessels may be easily aggravated, and eclamptic seizures may be induced in patients with severe preeclampsia, especially in those complicated by HELLP syndrome. The administration of anticholinergics should be avoided in patients with severe preeclampsia, especially when there is epigastralgia.


Asunto(s)
Antagonistas Colinérgicos/efectos adversos , Eclampsia/etiología , Convulsiones/etiología , Adulto , Bromuro de Butilescopolamonio/efectos adversos , Contraindicaciones , Eclampsia/fisiopatología , Femenino , Síndrome HELLP/etiología , Síndrome HELLP/fisiopatología , Humanos , Preeclampsia/tratamiento farmacológico , Preeclampsia/fisiopatología , Embarazo , Convulsiones/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA